alpha a2m major human plasma protease inhibitor capable inhibiting endopeptidases tested far case major plasma protease inhibitor alpha genetically determined deficiency states known increase risk chronic obstructive pulmonary disease copd affected individuals defects a2m gene described a2m play role regulation protease activity lung especially respect proteases inhibited alpha report molecular genetic detection alteration a2m gene patient serum a2m deficiency chronic lung disease childhood alteration involves restriction sites detected NUMBER different enzymes probably caused major deletion rearrangement gene restriction enzymes used detected polymorphisms NUMBER healthy control subjects NUMBER copd patients polymorphism detected patient enzyme pvuii different described previously patient patient heterozygous alteration a2m gene responsible serum a2m deficiency relevant early onset pulmonary disease case NUMBER macroglobulin NUMBER antitrypsin NUMBER NUMBER fold NUMBER antitrypsin